BRCA1 and endometrial cancer: In a systematic review that intended to summarize the findings of all published studies on the prevalence of BRCA1/2 mutation in patients with endometrial cancer, a total of 1613 patients enrolled into 11 clinical studies were tested for BRCA1/2 mutations and were included in the analysis.